MTRLF (Matricelf) EBITDA Margin %: 0.00% (As of . 20)


MTRLF Matricelf Ltd MTRLF
14 GF Score
Price $1.90
View Full Analysis

What is Matricelf EBITDA Margin %?

Matricelf MTRLF 14 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates MTRLF with a GF Score™ of 14/100. Among 945 Biotechnology companies, Matricelf ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Matricelf's EBITDA for the six months ended in . 20 was $0.00 Mil. Matricelf's Revenue for the six months ended in . 20 was $0.00 Mil. Therefore, Matricelf's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Matricelf  (OTCPK:MTRLF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Matricelf EBITDA Margin % Related Terms

Matricelf EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Matricelf's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Matricelf EBITDA Margin % Chart

Matricelf Annual Data
Trend
EBITDA Margin %

Matricelf Semi-Annual Data
EBITDA Margin %

MTRLF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Matricelf's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Matricelf EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matricelf's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Matricelf's EBITDA Margin % falls into.


MTRLF
14GF Score
Matricelf Ltd MTRLF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Matricelf EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Matricelf's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Matricelf's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Matricelf (MTRLF) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Matricelf and its competitors. According to the industry distribution chart, Matricelf ranks #999999 out of 945 companies in the Biotechnology industry.
Is Matricelf's EBITDA Margin % too high?
Matricelf's current EBITDA Margin % is 0.00%. Based on the distribution chart, Matricelf ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Matricelf has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Matricelf's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Matricelf ranks #999999 out of 945 companies for EBITDA Margin %. This places Matricelf in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Matricelf and its competitors. Matricelf's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Matricelf stock overvalued right now?
Matricelf (MTRLF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Matricelf's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Matricelf (MTRLF), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Matricelf Business Description

Other Exchanges MTLF:Israel
Address Golda Meir 3, Ness Ziona, ISR, 6701838
Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.
14GF Score

Get the complete analysis for MTRLF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price